ACTRN12621000015842已完成3 期
Effect of Palmitoylethanolamide (PEA) and Resveratrol compared to a placebo on menstrual pain symptoms in an Adult Female Population – A double blind, randomised controlled trial.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 131
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- Female
入选标准
- •Women who experience mild to moderate menstruating pain
- •- Aged 18-50 years old
- •- Otherwise healthy
- •- Able to provide informed consent
- •- Regular menstrual cycle (28 days ± 7 days) and period
排除标准
- •- Secondary cause for dysmenorrhea (i.e. endometriosis, adenomyosis, uterine fibroids or infection)
- •- Under or overweight (BMI <18.5 or >35kg/m2)
- •- Any bleeding disorders, recent surgery or concurrent blood thinning treatment
- •- Unstable or serious illness (eg kidney, liver, GIT, heart conditions, diabetes, thyroid gland function, malignancy, lung conditions, chronic asthma, diagnosed psychological or mood disorder)*
- •- Has or is currently suffering from any form of chronic disease in the past 6 months
- •- Use of any long-term medication that is related to dysmenorrhea or general pain
- •- Malignancy or treatment for malignancy within the previous 2 years
- •- Pregnant or lactating women
- •- Chronic past and/or current alcohol use (>14 alcoholic drinks week)
- •- Chronic smokers
- •- Allergic or hypersensitive to any of the ingredients in active or placebo formula
- •*An unstable illness is any illness that is currently not being treated with a stable dose of medication or is fluctuating in severity. A serious illness is a condition that carries a risk of mortality, negatively impacts quality of life and daily function and/or is burdensome in symptoms and/or treatments.
研究者
相似试验
招募中
3 期
Effect of Palmitoylethanolamide (PEA) and Oleoylethanolamide (OEA) Compared to a Placebo on the Gut Microbiome in an Adult Population – A double blind, randomised controlled trial.Gut microbiomeGut barrier functionGut biochemistryOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonAlternative and Complementary Medicine - Other alternative and complementary medicineMetabolic and Endocrine - Normal metabolism and endocrine development and functionACTRN12621000017820RDC Global Pty Ltd120
已完成
3 期
Effect of Palmitoylethanolamide (PEA) compared to a placebo on symptoms for upperrespiratory tract infection (URTI) in an Adult Population – A double blind, randomised controlledtrial.ACTRN12620000846921RDC Global Pty Ltd428
已完成
3 期
The effect of Palmitoylethanolamide (PEA) supplementation on the symptoms of allergic rhinitis - A double-blind placebo controlled trial.Allergic rhinitisInflammatory and Immune System - AllergiesACTRN12619001368123RDC Global Pty Ltd162
已完成
3 期
comparison of two drugs for checking effectiveness for nerve related paiCTRI/2021/08/036091Dr Amlendu shekhar60
尚未招募
4 期
Comparative analysis of Dietary Supplement vs Analgesic in managing pain after wisdom tooth removalCTRI/2024/08/072195Hemang Kapoor